The model included serum CK-18, fasting insulin, platelet count, sex, and HbA1c demonstrated good performance with an AUROC of 0.860 for advanced fibrosis detection among patients with T2DM [28]. This evidence concerns the gene KRT18 and type 2 diabetes mellitus.